Prometheus Biosciences, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Prometheus Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q1 2023.
  • Prometheus Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $9.38M, a 186% increase year-over-year.
  • Prometheus Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $27M, a 105% increase year-over-year.
  • Prometheus Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $20.9M, a 95% increase from 2021.
  • Prometheus Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $10.7M, a 1174% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $27M $9.38M +$6.1M +186% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $20.9M $6.92M +$4.47M +182% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-28
Q3 2022 $16.4M $6.03M -$223K -3.57% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $16.6M $4.64M +$3.43M +285% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $13.2M $3.28M +$2.49M +314% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $10.7M $2.45M +$2.13M +650% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $8.57M $6.25M +$6.05M +2994% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $2.52M $1.2M +$1.04M +634% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.49M $792K +$645K +439% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $840K $327K Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $202K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $164K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $147K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.